Breaking News
March 24, 2018 - TAVR Reasonable for Low-Flow, Low-Gradient Aortic Stenosis
March 24, 2018 - Kids with severe brain injuries may develop ADHD: study
March 24, 2018 - Researchers explore ways to help older adults taper off and stop using sedatives
March 24, 2018 - Back pain being mismanaged globally
March 24, 2018 - Fingerprint test accurately and noninvasively detects heroin, cocaine users
March 24, 2018 - Leading experts to promote cardiovascular health at EuroPrevent 2018
March 24, 2018 - A Role for Rituximab in Lupus?
March 24, 2018 - New osteoarthritis genes discovered
March 24, 2018 - Maternal intake of DHA supplement linked to higher fat-free body mass in children
March 24, 2018 - Royal College of Pathologists‘ bulletin provides summary of Tissue Handling Workshop
March 24, 2018 - Maternal alcohol use early in pregnancy may be risk factor for infant abdominal malformation
March 24, 2018 - Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection
March 24, 2018 - Accelerated WBI Should be the Norm for Most Breast Cancers
March 24, 2018 - Experts seek to standardize treatments for childhood rheumatic diseases
March 24, 2018 - Foil-based measuring chip rapidly detects Legionella
March 24, 2018 - Bariatric surgery linked to positive outcomes in very obese adolescents with type 2 diabetes
March 24, 2018 - Are there risks from secondhand marijuana smoke? Early science says yes.
March 24, 2018 - New University of Bath project seeks to make injections safer
March 24, 2018 - Higher-dose RT does not improve survival but reduces recurrence risk for prostate cancer patients
March 24, 2018 - Researchers examine link between knee pain and depression in older adults
March 24, 2018 - FDA Alert: BD Vacutainer Blood Collection Tubes by Becton, Dickinson and Company (BD): Class I Recall
March 24, 2018 - Daytime Sleepiness Linked to Amyloid Accumulation Without Dementia
March 24, 2018 - Energy storehouses in the brain may be source of Alzheimer’s, targets of new therapy
March 24, 2018 - Praising people with autism shows promise for producing more exercise
March 24, 2018 - Using harmless red or infrared light to diagnose breast cancer
March 24, 2018 - Clash over abortion hobbles a health bill. Again. Here’s how.
March 23, 2018 - Virtual nature environment could be new way to recover from stress
March 23, 2018 - New study identifies key cellular mechanisms behind vascular aging in mice
March 23, 2018 - Nightmares Common Among U.S. Troops, But Seldom Reported
March 23, 2018 - Another Record Low for Tuberculosis in U.S.
March 23, 2018 - Changes in the eye connected to a decline in memory
March 23, 2018 - Radiologist creates dramatic teaching tool using power of VR
March 23, 2018 - Grilled meat could be raising the risk of hypertension finds study
March 23, 2018 - Mutations found in bassoon gene may help explain cause of rare brain disorder
March 23, 2018 - Childhood Brain Injuries May be Linked to ADHD Years Later
March 23, 2018 - Why treating addiction with medication should be carefully considered
March 23, 2018 - Researchers make key discovery about cellular pathway linked to myriad of diseases
March 23, 2018 - Researchers uncover cause of rare childhood neurodegenerative disease
March 23, 2018 - Measles infection in early childhood could contribute to later COPD
March 23, 2018 - Opioid painkiller is top prescription in 11 states
March 23, 2018 - Sienna Biopharmaceuticals Announces First Patient Dosed In Proof-of-Concept Trial of Topical By Design™ JAK Inhibitor SNA-125 for Atopic Dermatitis
March 23, 2018 - In Teen Girls, Neural Patterns May Drive Emotional Resilience
March 23, 2018 - Gene-based test for urine detects, monitors bladder cancer
March 23, 2018 - BD to introduce new digital solution for IV chemotherapy administration process at EAHP 2018
March 23, 2018 - New computational method helps to identify tumor cell mutations with greater accuracy
March 23, 2018 - Researchers identify potential obesity treatment in freezing hunger-signaling nerve
March 23, 2018 - Wales participates in the 100,000 Genomes Project
March 23, 2018 - 24-Hr Paging Cuts ED Visits for Kids with Endocrine Issues
March 23, 2018 - The brain learns completely differently than we’ve assumed since the 20th century
March 23, 2018 - Less nutritious diet mainly contributes to Type 2 diabetes among U.S.-based South Asians
March 23, 2018 - Stony Brook Medicine expert provides tips for healthy diet to decrease cancer risk
March 23, 2018 - New findings could have revolutionary impact on quality of life of older people
March 23, 2018 - Restoring enzyme may help reverse effects of vascular aging, study shows
March 23, 2018 - Protein profiling reveals new prostate cancer mechanisms
March 23, 2018 - Depression may be linked to increased risk of atrial fibrillation
March 23, 2018 - FDA Takes Aim at Flavored Tobacco
March 23, 2018 - SMART Strategy Lowers Asthma Exacerbation Risk
March 23, 2018 - Cold open water plunge provides instant pain relief
March 23, 2018 - Portable and wearable technology supports future of military medical devices
March 23, 2018 - Patients with vascular malformations have poor health-related quality of life
March 23, 2018 - Researchers develop unique technology to overcome global antibiotic resistance crisis
March 23, 2018 - New DOD grant to support testing of promising therapy for triple-negative breast cancer
March 23, 2018 - Novel vaccine technologies can help better prepare for future infectious disease threats
March 23, 2018 - OncoBreak: Colonoscopy TV; Coverage for Genomic Testing; Care for Caregivers
March 23, 2018 - For some surgeries, nerve blocks mean better outcomes, fewer opioids
March 23, 2018 - Maternal obesity and androgen excess induce sex-specific anxiety in offspring, study suggests
March 23, 2018 - The tale of Theranos and the mysterious fire alarm
March 23, 2018 - USC researchers create algorithm to optimize substance abuse intervention groups
March 23, 2018 - Impulsivity may be associated with greater weight loss during treatment in obese children
March 23, 2018 - CTI BioPharma Announces Publication of Pacritinib Phase 3 PERSIST-2 Clinical Trial in JAMA Oncology
March 23, 2018 - Senate Panel Addresses Native Americans’ Opioid Troubles
March 23, 2018 - Brain connections in schizophrenia
March 23, 2018 - Mental health assessment in health checks can help detect psychologically vulnerable people
March 23, 2018 - New test for urothelial cancers offers less invasive, more accurate detection
March 23, 2018 - Groundbreaking 100,000 Genomes Project achieves important milestone to transform NHS care
March 23, 2018 - Mice getting a new lease of life with anti-aging pills
March 23, 2018 - Obesity kills taste buds and dulls taste sensation finds study
March 23, 2018 - Medical students get less formal education in radiation oncology, study finds
March 23, 2018 - Researchers find investigational compound to treat triple negative breast cancer after brain metastasis
March 23, 2018 - Researchers develop wearable system to monitor electrical activity in the stomach over 24 hours
Blood take a look at might expect medicine results for sufferers with localized NSCLC

Blood take a look at might expect medicine results for sufferers with localized NSCLC

image_pdfDownload PDFimage_print

A brand new learn about demonstrates blood take a look at to come across most cancers might expect medicine results for sufferers with localized non-small cellular lung most cancers (NSCLC) and come up with the money for physicians further lead time to personalize medicine for recurrent illness. Sufferers within the learn about with detectable ranges of circulating tumor DNA (ctDNA) in a while after medicine all had recurrences inside of two years, whilst all however one of the vital sufferers with out detectable ctDNA in a while after medicine remained disease-free and survived long-term. Typical imaging, conversely, was once no longer prognostic for recurrence or survival. Findings will probably be offered as of late on the 59th Annual Assembly of the American Society for Radiation Oncology (ASTRO).

The competitive nature of lung most cancers could make long-term control particularly difficult. As a result of NSCLC has a tendency to development, even following medicine, common tracking for recurrence is essential. The CT scans in most cases used for tracking, then again, are steadily not able to come across microscopic tumor deposits or to tell apart standard tissue adjustments led to via medicine from adjustments led to via recurrent illness.

“Blood exams that may come across minute lines of most cancers that stay after medicine may just make stronger recurrence tracking and probably be offering physicians months of extra lead time to tailor therapies and make stronger our sufferers’ results and high quality of lifestyles,” stated Aadel Chaudhuri, MD, PhD, lead writer of the learn about and a major resident in radiation oncology at Stanford College in Palo Alto, California.

“Our findings recommend that ctDNA research, in contrast to CT scans, can determine in a while after medicine of completion if a affected person with localized lung most cancers has most probably been cured via radiation or surgical operation or if she or he nonetheless has most cancers cells provide of their frame. Whilst we anticipated that ctDNA detection of molecular residual illness would expect deficient scientific results, we had been shocked via how strongly predictive the take a look at was once for recurrence and survival.”

Presence of ctDNA was once measured as a marker of molecular residual illness (MRD) in sufferers with degree I-III NSCLC instantly earlier than medicine and in a while after medicine was once finished. ctDNA ranges additionally had been measured mid-treatment (reasonable = Three weeks, vary = 1.Four-Three.7 weeks) for part of the sufferers receiving chemoradiation (n = 13 of 27 sufferers). Most cancers Customized Profiling via Deep Sequencing (CAPP-Seq) was once used to evaluate whether or not ctDNA was once provide. Surveillance scans the use of CT imaging had been evaluated the use of the Reaction Analysis Standards In Forged Tumors (RECIST).

The median affected person age was once 67 years (vary 47-91 years), and maximum sufferers (67%) had been male. All 41 sufferers had been handled with healing intent, together with with chemoradiation remedy (66%), radiation remedy on my own (27%) and surgical operation on my own (7%). Median follow-up for the learn about was once 35 months (vary 7-56 months).

Researchers detected ctDNA pretreatment in 38 of the 41 sufferers (93%). Thirty-four of those 38 sufferers had blood drawn inside of 4 months of medicine of completion (the prespecified MRD landmark) and had been eligible for next research.

A few of the 34 sufferers with ctDNA MRD pretreatment, greater than part (56%, n = 19) had detectable residual illness after medicine. All of those sufferers therefore evolved recurrent lung most cancers, in comparison with most effective one of the vital 15 sufferers with out detectable ctDNA MRD.

Sufferers with detectable ctDNA MRD after medicine had worse freedom from development and survival than sufferers with out detectable ctDNA MRD (freedom from development Danger Ratio (HR) =, p < zero.0001; disease-specific survival HR = 27.7, p < zero.0001). CT imaging on the identical time was once no longer prognostic for survival. ctDNA ranges earlier than medicine additionally weren't related to survival results.

In 8 of the 13 sufferers assessed mid-treatment, ctDNA accounted for zero.1 p.c or extra of all cell-free DNA. For those sufferers, mid-treatment ctDNA ranges predicted eventual illness development (HR = 2.7, p = zero.006). Sixty p.c of the sufferers with not up to zero.1 p.c ctDNA mid-treatment had been progression-free at two years following medicine, in comparison to not one of the sufferers with zero.1 p.c or upper ranges of ctDNA (HR = Four.Four, p = zero.037).

“Someday, clinicians could possibly use ctDNA research to spot sufferers who may just get pleasure from further medicine after first-line remedy,” stated Maximilian Diehn, MD, PhD, senior writer of the learn about and an assistant professor of radiation oncology at Stanford.

“In a similar learn about additionally offered at this yr’s ASTRO Annual Assembly, we discovered that ctDNA research detected illness recurrence a mean five.five months previous than standard-of-care CT imaging for localized lung most cancers and helped with interpretation of equivocal follow-up imaging. This implies that ctDNA research may just open a window to regard sufferers with residual most cancers early, whilst illness burden is minimum.”​

Tagged with:

About author

Related Articles